Pharma

Pfizer seeks closeness to Trump: Bourla and top management hold a meeting in Mar-a-Lago.

Pfizer CEO Bourla positions himself strategically in Mar-a-Lago, as the industry hopes for cooperation with the Trump administration.

Eulerpool News Jan 9, 2025, 12:12 PM

Pfizer CEO Albert Bourla and his leadership team have gathered for a multi-day offsite meeting at Donald Trump's Mar-a-Lago resort.

If I were CEO of a pharmaceutical company, I would also go to Mar-a-Lago," commented John LaMattina, former head of research and development at Pfizer.

Professional-grade financial intelligence

20M+ securities. Real-time data. Institutional insights.

Subscribe for $2

Trusted by professionals at Goldman Sachs, BlackRock, and JPMorgan

News

Technology

SK Hynix surpasses Samsung with record profit thanks to AI demand

SK Hynix achieves record profit thanks to AI-driven HBM demand, while Samsung falls behind in the competition for Nvidia.

Business

BNP Paribas defies volatility with strong bond trading – Weaknesses in equity business slow momentum

BNP Paribas achieves strong trading gains in the bond segment, while equities and investment banking clearly lag behind.

Business

Macquarie under Pressure: Shareholders Rebel Against Top Compensation Despite Regulatory Complaints

Despite growing criticism regarding compensation and regulatory issues, Macquarie remains on course for the time being—with increasing investor resistance.

Business

TotalEnergies warns of oversupply in the oil market - profits fall by 30 percent

TotalEnergies struggles with falling prices and oversupply, but remains committed to dividend policy - debts rise significantly.

Business

Nestlé puts US vitamin business under review – Future focus on higher-margin premium brands

Nestlé is considering the sale of weak vitamin brands and, under CEO Freixe, is focusing on specialization and margin strength.